Bo Tang

The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis

Liangren Liu, Q. Wei, Jinze Li, 2023, International journal of surgery.

Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice

J. Holst, P. Serup, D. S. Dichmann, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective

Zhe Zhang, B. Tang, Zongguang Zhou, 2021, Pharmaceutics.

ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor–activated cancer

T. Ho, Liguo Wang, Jun Zhang, 2021, Proceedings of the National Academy of Sciences.

MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression

Liguo Wang, Wanhai Xu, R. Karnes, 2021, Cancer Research.

Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation

Q. Wei, H. Cai, Kun-jie Wang, 2020, Journal of cellular and molecular medicine.

SETDB1 modulates degradation of phosphorylated RB and anti-cancer efficacy of CDK4/6 inhibitors.

Xin Jin, Yunqian Pan, Haojie Huang, 2023, Cancer research.